ãã¯ã¯ãã³ããšåŒã°ããŠããè¬å€ãžã®ç念ãã®äžéãŸãšãããã®â¡
â¢åè¬å€ã«å¯Ÿããç·èª¬
ããšããæ°åã³ããã¯ã¯ãã³æ¥çš®ãšæ»äº¡äºäŸã®å æé¢ä¿ãèãããå匷äŒã§ãçŠå³¶å çãäœåºŠãèšåããŠããç·èª¬è«æã¯ðã ã
billions of lives are potentially at risk, given the large number of individuals injected with the SARS-CoV-2 mRNA vaccines and the broad range of adverse outcomes we have described. We call on the public health institutions to demonstrate, with evidence, why the issues discussed in this paper are not relevant to public health, or to acknowledge that they are and to act accordingly.
SARS-CoV-2 mRNAã¯ã¯ãã³ã泚å°ãããå€ãã®å人ãšãæã ãæç€ºããå¹ åºãæå®³ãªçµæãèãããšãäœååãã®åœãå±éºã«ãããããå¯èœæ§ããã. æã ã¯ãå ¬è¡è¡çæ©é¢ã«å¯Ÿãããã®è«æã§è°è«ãããŠããåé¡ãå ¬è¡è¡çã«é¢ä¿ããªãçç±ã蚌æ ãšãšãã«ç€ºããããŸãã¯é¢ä¿ãããããšãèªããããã«å¿ããŠè¡åããããšãæ±ããã
ããã®ç·èª¬ããªããªãã®ããªã¥ãŒã ã§ãå€ãã®è«æãã¬ãã¥ãŒããŠãããã€ãŸã¿èªã¿ãããããä»ãŸã§ã®ãŸãšãããšããŠå€§å€æçšã«æããã ããåèš³ããŠèŠçŽããŠè§£èª¬ããŠãããªãããªã»ã»ã»ç§ã®ç¥èéãšè±èªåã§ã¯ããããå
šãŠèªè§£ããã®ã¯é£ããã»ã»ã»
ããªã®ã§ãç§ã®èœåã§å¯èœãªã¬ãã«ã§ããã®è¬å€ã«å¯Ÿããç念ããèªåã®çè§£ãæ·±ããŠããããã«ããŸãšããŠããã
â£ä»åã®è¬å€ã«å¯Ÿããç念ã®ãŸãšãã
ã仿Žã ãããã®ã¯ã¯ãã³ã¯ãäžæŽ»åã¯ã¯ãã³ããçã¯ã¯ãã³ããšèšãããŠãããã®ãšã¯æ©åºãå
šãéããããã¯ãmRNAå»è¬ãã§ãããéºäŒåæ²»çã®æŠå¿µã«å«ãŸãããæ¯èŒçæ°ããæè¡ã ãåžè²©è¬ãšããŠæ¿èªãå®çšåãããã®ããä»åãåããŠã ãæ²»çãšããŠäœ¿çšãããªããšããããå¥åº·äººã«åºã䜿çšããããšã§å¥åº·è¢«å®³ãå°ãªãããèµ·ããããšãããã¯çŽæã§ããããªãã®ã ãã
ãmRNAå»è¬ã«é¢ããŠã¯ãðã®è§£èª¬ãç§ã®é ã§ãååçè§£å¯èœã ã£ãã
ããšãããããðã®è¡šãèŠãŠãèšãããã®ãªãæ°è²æªããæããã®ã ããã©ãã ããïŒSARS CoV 2ããmRNAå»è¬ã®å®éšå°ã«ãªã£ãŠããããã«èŠãããåŸ ã¡ãã³ãŠãããã ãããªã»ã»ã»

ãã§ããå¥ã«ãã°ãã€ããã¯ãªãã®ã ããmRNAå»è¬ãã®ãã®ãåé¡ã ã£ãããã§ã¯ãªããäžèšè§£èª¬ã«ãäŸïŒè³ç±æ¥ç¥çµæ é€å åã®çºçŸïŒãããããã«ãçŸæ£ã®æ²»çã«æçšãªã¿ã³ãã¯è³ªãçºçŸããããã®ãªãçµæ§ãªããšã ãšæãããããã£ããããªã¹ã¯ãäžåãããšãååæåŸ
ã§ããã ããã
ãã§ããä»åã¯ãæ¯æ§ãææãããŠãããã¹ãã€ã¯èçœããç®çæåãšããŠçºçŸãããããšããã³ã³ã»ããããããã倱æã ã£ãã»ã»ã»ããããšããããmRNAå»è¬ããã¯ã¯ãã³ããšããŠäœ¿çšããããšãã€ãŸãããã«ãšã£ãŠç
åäœãšãªãç©ã®äžéšãèªå·±ã®çްèã«çºçŸãããããšããçºæ³èªäœã«ãåé¡ãããã®ã§ã¯ãªãã®ããïŒãã®æè¡ã¯ãæçšãªã¿ã³ãã¯è³ªãçºçŸããããæ²»çè¬ããšããŠã®å©çšã«ãšã©ããŠããã¹ããªã®ã§ã¯ãªãã®ããïŒä»åŸã®éçºã®ããã«ãããããã¯ã£ãããããŠããã¹ãã§ã¯ïŒãšãèå©å¿ãªããæã£ãŠããŸãã
ãããããããã ãæ¥çš®åŸã«ãççç±æ¥ãšããæããªãçºç±ãçŒçãèµ·ããã®ã§ããã°ãæ¥çš®ããmRNAããéèªå·±ããšããŠæé€ããã·ã¹ãã ãèªå°ãããŠãããã€ãŸããå
ç«åæ§ãããåé¿ã§ããŠããªãå¯èœæ§ããããããããmRNAã®ä¿®é£Ÿãæè¡çã«äžæããã£ãŠãªãããããªãã®ããïŒãšããçå¿µãæ¶ããªãã
ãããšãã»ã³ãã©ã«ãã°ãããæ³å®ããŠãªããã©ãæ¬åœã«é転åã¯èµ·ãããªãã®ããïŒä»¥åãé転åã®å¯èœæ§ã瀺åããè«æããã£ãããã«æãããããã¯ã©ããªã£ããã ãããã
ãé転åããªããšããŠãããããRNAãDNAã«æ¯ã¹ãŠäžå®å®ãšã¯ããã现èã«ç¡äºmRNAãéã蟌ãŸããæç¹ã§ããã®çްèãç®çãšããã¿ã³ãã¯è³ªãé·æéçºçŸãç¶ããããšããäºæ
ãèµ·ããå¯èœæ§ãããã¯ãã ããå®éããã®ãããªå¯èœæ§ã瀺åããè«æãåºãŠããããããã¯ã©ããªã®ããïŒ
